Your browser doesn't support javascript.
loading
The Oral ß-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.
Kokai-Kun, John F; Roberts, Tracey; Coughlin, Olivia; Sicard, Eric; Rufiange, Marianne; Fedorak, Richard; Carter, Christian; Adams, Marijke H; Longstreth, James; Whalen, Heidi; Sliman, Joseph.
Afiliação
  • Kokai-Kun JF; Synthetic Biologics, Inc., Rockville, Maryland, USA jkokai-kun@syntheticbiologics.com.
  • Roberts T; Synthetic Biologics, Inc., Rockville, Maryland, USA.
  • Coughlin O; Synthetic Biologics, Inc., Rockville, Maryland, USA.
  • Sicard E; Algorithme Pharma, Laval, Quebec, Canada.
  • Rufiange M; Algorithme Pharma, Laval, Quebec, Canada.
  • Fedorak R; University of Alberta/Alberta Health Service, Edmonton, Alberta, Canada.
  • Carter C; University of Alberta/Alberta Health Service, Edmonton, Alberta, Canada.
  • Adams MH; MH Adams & Associates, Inc., Davie, Florida, USA.
  • Longstreth J; Longstreth and Associates, Inc., Mundelein, Illinois, USA.
  • Whalen H; Synthetic Biologics, Inc., Rockville, Maryland, USA.
  • Sliman J; Synthetic Biologics, Inc., Rockville, Maryland, USA.
Article em En | MEDLINE | ID: mdl-28052855

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Proteínas Recombinantes / Ceftriaxona / Inativação Metabólica / Substâncias Protetoras / Disbiose / Antibacterianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Beta-Lactamases / Proteínas Recombinantes / Ceftriaxona / Inativação Metabólica / Substâncias Protetoras / Disbiose / Antibacterianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article